Intradermal grass pollen immunotherapy increases T<sub>H</sub>2 and IgE responses and worsens respiratory allergic symptoms.

J Allergy Clin Immunol · 2017 · PMC5457129 · PMID 27773851

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

tended toward significanceno p-value reported

In the per-protocol analysis ( Table III ) the individual nasal ( P = .02) and mouth ( P = .02) daily symptom scores were significantly higher in the active group, whereas lung daily symptom scores ( P = .05) and overall symptom scores ( P = .09) tended toward significance.

also in 121 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Intradermal grass pollen immunotherapy increases T&lt;sub&gt;H&lt;/sub&gt;2 and IgE responses and worsens respiratory allergic symptoms.

The sentences

Intradermal grass pollen immunotherapy increases T<sub>H</sub>2 and IgE responses and worsens respiratory allergic symptoms.